⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
EXAS News
Exact Sciences Corp
Exact Sciences Announces Expiration of the HSR Waiting Period for Exclusive License to Freenome’s Blood-Based Colorectal Cancer Screening Tests
businesswire.com
EXAS
Exact Sciences Announces Breakthrough Results from Landmark Study Demonstrating Superior Early Detection of Liver Cancer with Blood-Based Surveillance Test
businesswire.com
EXAS
Exact Sciences to Participate in November Investor Conference
businesswire.com
EXAS
Exact Sciences Announces Third Quarter 2025 Results
businesswire.com
EXAS
Exact Sciences Presents New Findings at ACG 2025 Demonstrating How the Cologuard Test Helps Improve Adherence and Close Screening Gaps
businesswire.com
EXAS
EXAS
Exact Sciences Schedules Third Quarter 2025 Earnings Call
businesswire.com
EXAS
EXAS
New Study in Journal of the National Cancer Institute Finds Cologuard Plus™ Provides the Most Life-Years Gained with the Fewest Colonoscopies
businesswire.com
EXAS
EXAS
Horror Icon Matthew Lillard and Exact Sciences Help Adults 45+ Conquer Fear and Get Screened for Colon Cancer with the Cologuard ® Test
businesswire.com
EXAS
EXAS